Repeatability of OCT and IV-US in Pulmonary Arterial Hypertension

Not Applicable

Completed

• Conditions: Pulmonary Arterial Hypertension
• Interventions: Procedure: Patients with Pulmonary Arterial Hypertension

• Registration Number: NCT03105934
• Lead Sponsor: Hospital Universitari Vall d'Hebron Research Institute

Brief Summary

To assess the correlation between pulmonary IV-OCT and pulmonary IV-US measurements and standard PAH clinical measures of disease progression and the relative sensitivity of the techniques to change.

Detailed Description

Not available

Study Timeline

• Study Start: 2016-04
• Study First Submitted: 2017-04-04
• Study First Submitted QC: 2017-04-04
• Study First Posted: 2017-04-10
• Primary Completion: 2017-10-18
• Study Completion: 2018-01-25
• Status Verified: 2018-02
• Last Update Submitted: 2018-02-09
• Last Update Posted: 2018-02-12

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

• With confirmed diagnosis of PAH Group 1 according to the ESC/ERS Guidelines
• With severe disease, defined as Class II- III of the modified WHO functional classes in the ESC/ERS Guidelines

Exclusion Criteria

• That according to investigator criteria cannot participate in the trial

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Pulmonary Arterial Hypertension	Patients with Pulmonary Arterial Hypertension	Patients with Pulmonary Arterial Hypertension

Primary Outcome Measures

Name	Time	Method
Image measurements	12 months	Repeat acquisitions to be made in the same regions and in locations

Trial Locations

Locations (1)

Hospital Vall d'Hebron; 🇪🇸 Barcelona, Spain